$MD
Pediatrix Medical Group, Inc.

2015 Q3 Form 10-Q Financial Statement

#000119312515358077 Filed on October 29, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2014 Q3
Revenue $722.3M $626.5M
YoY Change 15.29% 12.94%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $530.2M $455.4M
YoY Change 16.43% 13.42%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $16.92M $11.36M
YoY Change 48.98% 8.56%
% of Gross Profit
Operating Expenses $571.1M $488.4M
YoY Change 16.95% 13.19%
Operating Profit $151.1M $138.1M
YoY Change 9.4% 12.05%
Interest Expense $6.201M $2.019M
YoY Change 207.13% 33.97%
% of Operating Profit 4.1% 1.46%
Other Income/Expense, Net -$4.850M -$731.0K
YoY Change 563.47% -35.59%
Pretax Income $146.3M $137.4M
YoY Change 6.45% 12.49%
Income Tax $55.64M $51.17M
% Of Pretax Income 38.04% 37.24%
Net Earnings $90.78M $86.21M
YoY Change 5.31% 12.02%
Net Earnings / Revenue 12.57% 13.76%
Basic Earnings Per Share $0.98 $0.87
Diluted Earnings Per Share $0.97 $0.86
COMMON SHARES
Basic Shares Outstanding 92.95M shares 99.09M shares
Diluted Shares Outstanding 93.65M shares 100.1M shares

Balance Sheet

Concept 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $68.90M $79.10M
YoY Change -12.9% 273.11%
Cash & Equivalents $60.92M $71.82M
Short-Term Investments $8.000M $7.300M
Other Short-Term Assets $11.98M $10.82M
YoY Change 10.76% 14.9%
Inventory
Prepaid Expenses $10.04M $8.778M
Receivables $406.8M $345.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $573.2M $481.1M
YoY Change 19.15% 28.98%
LONG-TERM ASSETS
Property, Plant & Equipment $82.87M $63.60M
YoY Change 30.31% 4.37%
Goodwill $3.348B $2.659B
YoY Change 25.89% 12.96%
Intangibles
YoY Change
Long-Term Investments $59.30M $61.80M
YoY Change -4.05% 0.0%
Other Assets $483.4M $212.4M
YoY Change 127.53% 63.45%
Total Long-Term Assets $3.973B $2.997B
YoY Change 32.57% 14.97%
TOTAL ASSETS
Total Short-Term Assets $573.2M $481.1M
Total Long-Term Assets $3.973B $2.997B
Total Assets $4.546B $3.478B
YoY Change 30.71% 16.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.34M $22.17M
YoY Change 0.75% 93.25%
Accrued Expenses $329.3M $278.1M
YoY Change 18.41% 13.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $11.80M $300.0K
YoY Change 3833.33% 200.0%
Total Short-Term Liabilities $404.6M $329.3M
YoY Change 22.87% 20.18%
LONG-TERM LIABILITIES
Long-Term Debt $1.351B $288.2M
YoY Change 368.6% 132.98%
Other Long-Term Liabilities $57.22M $54.51M
YoY Change 4.98% -13.91%
Total Long-Term Liabilities $57.22M $54.51M
YoY Change 4.98% -13.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $404.6M $329.3M
Total Long-Term Liabilities $57.22M $54.51M
Total Liabilities $2.213B $973.1M
YoY Change 127.39% 30.48%
SHAREHOLDERS EQUITY
Retained Earnings $1.415B $1.604B
YoY Change -11.83% 14.19%
Common Stock $918.5M $1.003M
YoY Change 91473.38% 99.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.333B $2.504B
YoY Change
Total Liabilities & Shareholders Equity $4.546B $3.478B
YoY Change 30.71% 16.72%

Cashflow Statement

Concept 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income $90.78M $86.21M
YoY Change 5.31% 12.02%
Depreciation, Depletion And Amortization $16.92M $11.36M
YoY Change 48.98% 8.56%
Cash From Operating Activities $172.2M $159.4M
YoY Change 8.03% 0.95%
INVESTING ACTIVITIES
Capital Expenditures -$7.200M -$3.600M
YoY Change 100.0% 5.88%
Acquisitions
YoY Change
Other Investing Activities -$237.1M -$214.0M
YoY Change 10.79% 179.74%
Cash From Investing Activities -$244.3M -$217.7M
YoY Change 12.22% 172.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 67.80M 112.3M
YoY Change -39.63% -249.73%
NET CHANGE
Cash From Operating Activities 172.2M 159.4M
Cash From Investing Activities -244.3M -217.7M
Cash From Financing Activities 67.80M 112.3M
Net Change In Cash -4.300M 54.00M
YoY Change -107.96% 1641.94%
FREE CASH FLOW
Cash From Operating Activities $172.2M $159.4M
Capital Expenditures -$7.200M -$3.600M
Free Cash Flow $179.4M $163.0M
YoY Change 10.06% 1.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
600000000
CY2015Q1 us-gaap Accelerated Share Repurchases Settlement Payment Or Receipt
AcceleratedShareRepurchasesSettlementPaymentOrReceipt
200000000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71822000
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
93992000 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5400000 shares
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
93992000 shares
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
1165500000
CY2015Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
917541000
CY2015Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
33986000
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
2333135000
CY2015Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
11792000
CY2015Q3 us-gaap Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High
BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
4000000
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
57220000
CY2015Q3 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
29000000
CY2015Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
41136000
CY2015Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
351644000
CY2015Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
29400000
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
22340000
CY2015Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
188800000
CY2015Q3 us-gaap Malpractice Loss Contingency Accrual Undiscounted Noncurrent
MalpracticeLossContingencyAccrualUndiscountedNoncurrent
181410000
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
970178000
CY2015Q3 us-gaap Business Combination Contingent Consideration Arrangements Range Of Outcomes Value Low
BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow
0
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1414654000
CY2015Q3 us-gaap Malpractice Loss Contingency Accrual Undiscounted Current
MalpracticeLossContingencyAccrualUndiscountedCurrent
28431000
CY2015Q3 us-gaap Liabilities
Liabilities
2212754000
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4546495000
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
940000
CY2015Q3 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
7000000
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2333741000
CY2015Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
400000
CY2015Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
3800000
CY2015Q3 us-gaap Minority Interest
MinorityInterest
606000
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
404572000
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q3 us-gaap Business Acquisition Equity Interest Issued Or Issuable Value Assigned
BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
7800000
CY2015Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
219051000
CY2015Q3 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
14300000
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
483351000
CY2015Q3 us-gaap Assets
Assets
4546495000
CY2015Q3 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
39800000
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
406761000
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82873000
CY2015Q3 us-gaap Assets Current
AssetsCurrent
573178000
CY2015Q3 us-gaap Other Assets Current
OtherAssetsCurrent
11982000
CY2015Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
18700000
CY2015Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
18700000
CY2015Q3 us-gaap Goodwill
Goodwill
3347823000
CY2015Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
8021000
CY2015Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10039000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60915000
CY2015Q3 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
59270000
CY2015Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
75460000
CY2015Q3 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
55353000
CY2015Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1376939000
CY2015Q3 us-gaap Held To Maturity Securities Debt Maturities After Five Through Ten Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount
3917000
CY2015Q3 md Accrued Payroll Taxes And Benefits Current
AccruedPayrollTaxesAndBenefitsCurrent
57775000
CY2015Q3 md Accrued Contingent Consideration Liability Current
AccruedContingentConsiderationLiabilityCurrent
13312000
CY2015Q3 md Accounts Payable And Accrued Liabilities Excluding Accrued Income Taxes Current
AccountsPayableAndAccruedLiabilitiesExcludingAccruedIncomeTaxesCurrent
351644000
CY2015Q3 md Long Term Debt And Capital Lease Obligations Excluding Long Term Line Of Credit
LongTermDebtAndCapitalLeaseObligationsExcludingLongTermLineOfCredit
185001000
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
94041485 shares
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31137000
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
96030000 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
96030000 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
368000000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
886877000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
29899000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
2264619000
CY2014Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
10465000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
58963000
CY2014Q4 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
35300000
CY2014Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
25150000
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
380658000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
25900000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
32783000
CY2014Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
231390000
CY2014Q4 us-gaap Malpractice Loss Contingency Accrual Undiscounted Noncurrent
MalpracticeLossContingencyAccrualUndiscountedNoncurrent
148651000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
848767000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1376782000
CY2014Q4 us-gaap Malpractice Loss Contingency Accrual Undiscounted Current
MalpracticeLossContingencyAccrualUndiscountedCurrent
19718000
CY2014Q4 us-gaap Liabilities
Liabilities
1343229000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3608795000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
960000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2265566000
CY2014Q4 us-gaap Minority Interest
MinorityInterest
947000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
416273000
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
160487000
CY2014Q4 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
16000000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
235425000
CY2014Q4 us-gaap Assets
Assets
3608795000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
352191000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
66048000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
467052000
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
7901000
CY2014Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
5100000
CY2014Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
5100000
CY2014Q4 us-gaap Goodwill
Goodwill
2776188000
CY2014Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
6035000
CY2014Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7036000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47928000
CY2014Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
64082000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100168000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1377000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
98791000 shares
us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
98791000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.32
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
45961000
CY2014Q4 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
54959000
CY2014Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1200958000
CY2014Q4 us-gaap Held To Maturity Securities Debt Maturities After Five Through Ten Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount
9123000
CY2014Q4 md Accrued Payroll Taxes And Benefits Current
AccruedPayrollTaxesAndBenefitsCurrent
49858000
CY2014Q4 md Accrued Contingent Consideration Liability Current
AccruedContingentConsiderationLiabilityCurrent
17010000
CY2014Q4 md Accounts Payable And Accrued Liabilities Excluding Accrued Income Taxes Current
AccountsPayableAndAccruedLiabilitiesExcludingAccruedIncomeTaxesCurrent
380658000
CY2014Q4 md Long Term Debt And Capital Lease Obligations Excluding Long Term Line Of Credit
LongTermDebtAndCapitalLeaseObligationsExcludingLongTermLineOfCredit
190855000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.28
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
243834000
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
2.62
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
2.66
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
100168000 shares
us-gaap Malpractice Loss Contingency Period Increase Decrease
MalpracticeLossContingencyPeriodIncreaseDecrease
9575000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
84000
us-gaap Net Income Loss
NetIncomeLoss
228883000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
262828000
us-gaap Profit Loss
ProfitLoss
228923000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3168000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
127759000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
346071000
us-gaap Operating Income Loss
OperatingIncomeLoss
371913000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1680000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
19604000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2170000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
49996000
us-gaap Investment Income Net
InvestmentIncomeNet
2533000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
1788389000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
369743000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
2193577000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
823500000
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
11405000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
875000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
140820000
us-gaap Share Based Compensation
ShareBasedCompensation
23914000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
40685000
us-gaap Operating Expenses
OperatingExpenses
1416476000
us-gaap Interest Expense
InterestExpense
5578000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-362580000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
14500000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
159431000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-506000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
10410000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
24140000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2711000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-12573000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23900000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
179886000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1084000000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5502000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
1025000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
11159000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32088000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
40000
md Payment Of Contingent Consideration Liability Financing
PaymentOfContingentConsiderationLiabilityFinancing
9550000
md Payment Of Contingent Consideration Liability Operating
PaymentOfContingentConsiderationLiabilityOperating
3851000
md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
65452000
md Practice Salaries And Benefits
PracticeSalariesAndBenefits
1139050000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.59
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
264565000
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
2.71
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
2.74
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
11 Acquisition
dei Amendment Flag
AmendmentFlag
false
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000893949
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
94123000 shares
us-gaap Malpractice Loss Contingency Period Increase Decrease
MalpracticeLossContingencyPeriodIncreaseDecrease
2814000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
MEDNAX, INC.
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
94123000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
928000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
93195000 shares
us-gaap Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued
BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
114306 shares
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
93195000 shares
dei Trading Symbol
TradingSymbol
MD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.61
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
3000000 shares
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
1063000
us-gaap Net Income Loss
NetIncomeLoss
243618000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
255260000
us-gaap Profit Loss
ProfitLoss
243277000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4480000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
235051000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
806304000
us-gaap Operating Income Loss
OperatingIncomeLoss
406908000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-6980000
us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
840900000
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
10100000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
20382000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11174000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17623000
us-gaap Investment Income Net
InvestmentIncomeNet
1093000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
2038256000
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
11500000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1227000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
395734000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
2197727000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1056500000
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
19908000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2350000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
152457000
us-gaap Share Based Compensation
ShareBasedCompensation
23960000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2062000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12987000
us-gaap Operating Expenses
OperatingExpenses
1631348000
us-gaap Interest Expense
InterestExpense
14617000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-823386000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
23208000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
571808000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-16000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2870000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16722000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1183000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-52734000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24000000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
220522000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1846500000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
15954000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
11467000
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
23200000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
235100000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
46079000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-341000
md Payment Of Contingent Consideration Liability Financing
PaymentOfContingentConsiderationLiabilityFinancing
9040000
md Payment Of Contingent Consideration Liability Operating
PaymentOfContingentConsiderationLiabilityOperating
1045000
md Business Acquisition Contingent Consideration At Fair Value Decrease
BusinessAcquisitionContingentConsiderationAtFairValueDecrease
800000
md Business Combination Contingent Consideration Arrangements Time Period
BusinessCombinationContingentConsiderationArrangementsTimePeriod
P2Y
md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
72316000
md Assumed Payment Probability Of Contingent Consideration Payment
AssumedPaymentProbabilityOfContingentConsiderationPayment
1.00 pure
md Increase Decrease In Accrued Payroll Taxes And Benefits
IncreaseDecreaseInAccruedPayrollTaxesAndBenefits
-42600000
md Number Of Physician Group Practices Acquired
NumberOfPhysicianGroupPracticesAcquired
9 Company
md Number Of Anesthesiology Practices Acquired
NumberOfAnesthesiologyPracticesAcquired
6 Company
md Number Of Neonatology Practices Acquired
NumberOfNeonatologyPracticesAcquired
2 Company
md Number Of Other Pediatric Subspecialty Practices Acquired
NumberOfOtherPediatricSubspecialtyPracticesAcquired
1 Company
md Practice Salaries And Benefits
PracticeSalariesAndBenefits
1292431000
md Payments To Acquire Businesses Net Of Cash Acquired Excluding Prior Period Adjustments
PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingPriorPeriodAdjustments
805700000
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100145000 shares
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1057000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99088000 shares
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
86207000
CY2014Q3 us-gaap Profit Loss
ProfitLoss
86238000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
138143000
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-731000
CY2014Q3 us-gaap Investment Income Net
InvestmentIncomeNet
563000
CY2014Q3 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
626506000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
137412000
CY2014Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
725000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51174000
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
488363000
CY2014Q3 us-gaap Interest Expense
InterestExpense
2019000
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8100000
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
60643000
CY2014Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11356000
CY2014Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
31000
CY2014Q3 md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
21570000
CY2014Q3 md Practice Salaries And Benefits
PracticeSalariesAndBenefits
394794000
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.97
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
93646000 shares
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
697000 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92949000 shares
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.98
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
90781000
CY2015Q3 us-gaap Profit Loss
ProfitLoss
90640000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
151130000
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4850000
CY2015Q3 us-gaap Investment Income Net
InvestmentIncomeNet
567000
CY2015Q3 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
722273000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
146280000
CY2015Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
784000
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
80185000
CY2015Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16918000
CY2015Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-141000
CY2015Q3 md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
24007000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55640000
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
571143000
CY2015Q3 us-gaap Interest Expense
InterestExpense
6201000
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8200000
CY2015Q3 md Practice Salaries And Benefits
PracticeSalariesAndBenefits
450033000

Files In Submission

Name View Source Status
0001193125-15-358077-index-headers.html Edgar Link pending
0001193125-15-358077-index.html Edgar Link pending
0001193125-15-358077.txt Edgar Link pending
0001193125-15-358077-xbrl.zip Edgar Link pending
d49195d10q.htm Edgar Link pending
d49195dex311.htm Edgar Link pending
d49195dex312.htm Edgar Link pending
d49195dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
md-20150930.xml Edgar Link completed
md-20150930.xsd Edgar Link pending
md-20150930_cal.xml Edgar Link unprocessable
md-20150930_def.xml Edgar Link unprocessable
md-20150930_lab.xml Edgar Link unprocessable
md-20150930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending